Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptor

International Journal of Molecular Sciences

Volumn 11, Issue 12, 2010, Pages 5310-5322

  Rong, Han ^a,b   Wang, Gaohua ^a   Liu, Tiebang ^b   Wang, Huiling ^a   Wan, Qirong ^a   Weng, Senghong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b SHENZHEN KANGNING HOSPITAL   (China)

Author keywords

Chronic mild stress; RAGE; S100B

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; FLUOXETINE; PROTEIN S100B; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; ANTIDEPRESSANT AGENT; IMMUNOGLOBULIN RECEPTOR; S100B PROTEIN, RAT;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; DRUG MECHANISM; DRUG TARGETING; FOOD INTAKE; HIPPOCAMPUS; MALE; NONHUMAN; OPEN FIELD TEST; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED; CHRONIC DISEASE; DRUG EFFECTS; HUMAN; MENTAL STRESS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ANIMAL; CHRONIC DISEASE; DEPRESSION; FLUOXETINE; HIPPOCAMPUS; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; STRESS, PSYCHOLOGICAL;

EID: 78650983356     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11125310     Document Type: Article

References (32)

1. Rajkowska, G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 2000, 48, 766-777.
2. Arolt, V.; Peters, M.; Erfurth, A.; Wiesmann, M.; Missler, U.; Rudolf, S.; Kirchner, H.; Rothermundt, M. S100B and response to treatment in major depression: a pilot study. Eur. Neuropsychopharmacol. 2003, 13, 235-239.
3. Dietrich, D.E.; Hauser, U.; Peters, M.; Zhang, Y.; Wiesmann, M.; Hasselmann, M.; Rudolf, S.; Jüngling, H.; Kirchner, O.; Münte, T.; Arolt, V.; Emrich, H.M.; Sonke, J.; Rothermundt, M. Target evaluation processing correlates with serum levels of nerve tissue protein S100B in patients with remitted major depression. Neurosci. Lett. 2004, 354, 69-73.
4. Veena, J.; Srikumar, B.N.; Raju, T.R.; Shankaranarayana Rao, B.S. Exposure to enriched environment restores the survival and differentiation of new born cells in the hippocampus and ameliorates depressive symptoms in chronically stressed rats. Neurosci. Lett. 2009, 455, 178-182.
5. Akhisaroglu, M.; Manev, R.; Akhisaroglu, E.; Uz, T.; Manev, H. Both aging and chronic fluoxetine increase S100B content in the mouse hippocampus. Neuroreport 2003, 14, 1471-1473.
6. Tramontina, A.C.; Tramontina, F.; Bobermin, L.D.; Zanotto, C.; Souza, D.F.; Leite, M.C.; Nardin, P.; Gottfried, C.; Gonçalves, C.A. Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32, 1580-1583.
7. Donato, R.; Rauvala, H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 2000, 275, 40096-40105.
8. Hofmann, M.A.; Drury, S.; Fu, C.; Qu, W.; Taguchi, A.; Lu, Y.; Avila, C.; Kambham, N.; Bierhaus, A.; Nawroth, P.; Neurath, M.F.; Slattery, T.; Beach, D.; McClary, J.; Nagashima, M.; Morser, J.; Stern, D.; Schmidt, A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97, 889-901.
9. Huttunen, H.J.; Kuja-Panula, J.; Sorci, G.; Agneletti, A.L.; Schmidt, A.M.; Yan, S.D.; Yan, S.F.; Stern, D.M. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 2000, 1498, 99-111.
10. Santilli, F.; Vazzana, N.; Bucciarelli, L.G.; Davi, G. Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr. Med. Chem. 2009, 16, 940.
11. Surget, A.; Saxe, M.; Leman, S.; Ibarguen-Vargas, Yadira.; Chalon, S.; Griebel, G.; Hen, R.; Belzung, C. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol. Psychiatry 2008, 64, 293-301.
12. van Eldik, L.J.; Wainwright, M.S. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor. Neurol. Neurosci. 2003, 21, 97-108.
13. Sakatani, S.; Seto-Ohshima, A.; Shinohara, Y.; Yamamoto, Y.; Yamamoto, H.; Itohara, S.; Hirase, H. Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gamma oscillations in vivo. J. Neurosci. 2008, 43, 10928-10936.
14. Sakatani, S.; Seto-Ohshima, A.; Itohara, S.; Hirase, H. Impact of S100B on local field potential patterns in anesthetized and kainic acid-induced seizure conditions in vivo. Eur. J. Neurosci. 2007, 25, 1144-1154.
15. Tramontina, A.C.; Tramontina, F.; Bobermin, L.D.; Zanotto, C.; Souza, D.F.; Leite, M.C.; Nardin, P.; Gottfried, C.; Gonçalves, C.A. Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32, 1580-1583.
16. Newton, S.S.; Duman, R.S. Regulation of neurogenesis and angiogenesis in depression. Curr. Neurovasc. Res. 2004, 1, 261-267.
17. Magdalena, N.J.; Christina, F.B.; Mark, J.W.; Ove, W. The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology 2008, 54, 530-541.
18. Kleindienst, A.; McGinn, M.J.; Harvey, H.B.; Colello, R.J.; Hamm, R.J.; Bullock, M.R. Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury. J. Neurotrauma 2005, 22, 645-655.
19. Donato, R. S100: a multigenetic family of calcium-modulated proteins of EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 2001, 33, 637-668.
20. Grabe, H.J.; Ahrens, N.; Rose, H.J.; Keller, C.; Freyberger, H.J. Neurotrophic factor S100beta in major depression. Neuropsychobiology 2001, 44, 88-90.
21. Rothermundt, M.; Peters, M.; Prehn, J.H.M.; Arolt, V. S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 2003, 60, 614-632.
22. Manev, R.; Uz, T.; Manev, H. Fluoxetine increases the content of neurotrophic protein S100b in the rat hippocampus. Eur. J. Pharmacol. 2001, 420, R1-R2.
23. Malberg, J.E.; Eisch, A.J.; Nestler, E.J.; Duman, R.S. Chronic antidepressant treatment increases neurogenesis in a subunit adult rat hippocampus. J. Neurosci. 2000, 20, 9104-9110.
24. Shi Fang, Y.; Ravichandran, R.; Ann, M.S. Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem. Pharmacol. 2010, 79, 1379-1386.
25. Wittkowski, H.; Hirono, K.; Ichida, F.; Vogl, T.; Ye, F. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12. Arthritis Rheum. 2007, 56, 4174-4181.
26. Strekalova, T.; Spanagel, R.; Bartsch, D.; Henn, F.A. Gass, P. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 2004, 29, 2007-2017.
27. Bergstrom, A.; Jayatissa, M.N.; Mørk, A.; Wiborg, O. Stress sensitivity and resilience in the chronic mild stress rat model of depression: an in situ hybridization study. Brain Res. 2008, 27, 41-52.
28. Grippo, A.J.; Beltz, T.G.; Weiss, R.M.; Johnson, A.K. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biol. Psychiatry 2006, 59, 309-316.
29. Itoh, T.; Tokumura, M.; Abe, K. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE binding activity and BDNF level in learned helplessness rats. Eur. J. Pharmacol. 2004, 498, 135-142.
30. Sakatani, S.; Yamada, K.; Homma, C.; Munesue, S.; Yamamoto, Y.; Yamamoto, H.; Hirase, H. Deletion of RAGE causes hyperactivity and increased sensitivity to auditory stimuli in mice. PLoS One 2009, 15, 8309.
31. Willner, P.; Towell, A.; Sampson, D.; Sophokleous, S.; Muscat, R. Reduction of sucrose preference by chronic unpredictable mild stress and its restoration by a tricyclic antidepressant. Psychopharmacology 1987, 93, 358-364.
32. Pardon, M.C.; Perez-Diaz, F.; Joubert, C.; Cohen-Salmon, C. Influence of chronic ultramild stress procedure on decision-making in mice. J. Psychiatry Neurosci. 2000, 25, 167-177.